<SEC-DOCUMENT>0001485003-19-000093-index.html : 20191114 <SEC-HEADER>0001485003-19-000093.hdr.sgml : 20191114 <ACCEPTANCE-DATETIME>20191114164114 ACCESSION NUMBER: 0001485003-19-000093 CONFORMED SUBMISSION TYPE: S-8 PUBLIC DOCUMENT COUNT: 5 FILED AS OF DATE: 20191114 DATE AS OF CHANGE: 20191114 EFFECTIVENESS DATE: 20191114 FILER: COMPANY DATA: COMPANY CONFORMED NAME: Sesen Bio, Inc. CENTRAL INDEX KEY: 0001485003 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 262025616 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: S-8 SEC ACT: 1933 Act SEC FILE NUMBER: 333-234697 FILM NUMBER: 191221100 BUSINESS ADDRESS: STREET 1: 245 FIRST STREET STREET 2: SUITE 1800 CITY: CAMBRIDGE STATE: MA ZIP: 02142 BUSINESS PHONE: 617-444-8550 MAIL ADDRESS: STREET 1: 245 FIRST STREET STREET 2: SUITE 1800 CITY: CAMBRIDGE STATE: MA ZIP: 02142 FORMER COMPANY: FORMER CONFORMED NAME: Eleven Biotherapeutics, Inc. DATE OF NAME CHANGE: 20100223 </SEC-HEADER> <DOCUMENT> <TYPE>S-8 <SEQUENCE>1 <FILENAME>sesn-formsx8newequityplans.htm <DESCRIPTION>S-8 <TEXT> Document 1 - file: sesn-formsx8newequityplans.htm
</DOCUMENT> <DOCUMENT> <TYPE>EX-5.1 <SEQUENCE>2 <FILENAME>sesn-exhibit51november2019.htm <DESCRIPTION>EXHIBIT 5.1 <TEXT> Document 2 - file: sesn-exhibit51november2019.htm
</DOCUMENT> <DOCUMENT> <TYPE>EX-23.1 <SEQUENCE>3 <FILENAME>forms-8consentey.htm <DESCRIPTION>EXHIBIT 23.1 <TEXT> Document 3 - file: forms-8consentey.htm
</DOCUMENT> <DOCUMENT> <TYPE>EX-99.3 <SEQUENCE>4 <FILENAME>exhibitsesen_omarrifi-stoc.htm <DESCRIPTION>EXHIBIT 99.3 <TEXT> Document 4 - file: exhibitsesen_omarrifi-stoc.htm
</DOCUMENT> <DOCUMENT> <TYPE>GRAPHIC <SEQUENCE>5 <FILENAME>sesnexhibit51november_image1.jpg <TEXT> Document 5 - file: sesnexhibit51november_image1.jpg
</DOCUMENT> </SEC-DOCUMENT>